  See all
 |
Articles: Stomach/GI |
Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders
Hepatology, 10/26/09
Influence of cyclooxygenase inhibitors on the function of the prostaglandin transporter OATP2A1 expressed in human gastroduodenal mucosa
Journal of Pharmacology and Experimental Therapeutics, 10/26/09 Anti-Egfr Therapy in Colorectal Cancer: How to Choose The Right Patient
Current Drug Targets, 10/23/09 Safety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience
Alimentary Pharmacology and Therapeutics, 10/23/09 Neonatal Peritoneal Candidiasis Successfully Treated with Anidulafungin Add-On Therapy
Annals of Pharmacotherapy, 10/22/09 A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis: A Randomized Placebo-controlled Trial
Journal of Clinical Gastroenterology, 10/22/09 Visceral fat area is an Independent Predictive Biomarker of Outcome after First-Line Bevacizumab-Based Therapy in Metastatic Colorectal Cancer
Gut, 10/22/09
Exclusive Author Commentary Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomized, placebo-controlled, double-blind trial
Gut, 10/22/09 Treatment of insulin resistance with metformin in naive genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin
Hepatology, 10/22/09 Contribution of the different UDP-glucuronosyltransferase isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomes
Drug Metabolism and Disposition, 10/21/09 Impact of Preoperative Bevacizumab on Complications After Resection of Colorectal Liver Metastases: Case-Matched Control Study
World Journal of Surgery, 10/21/09 Repligen Announces Completion of Patient Treatment in Phase 3 Clinical Trial of RG1068 in MRI Imaging of the Pancreas
Repligen, 10/20/09
Free full text
XenoPort Announces Initiation of a Phase 2b Clinical Trial of Arbaclofen Placarbil in Patients with Gastroesophageal Reflux Disease
XenoPort, 10/20/09 Dexlansoprazole MR
Expert Opinion in Pharmacotherapy, 10/19/09 Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events
Hepatology, 10/19/09 Management of Reflux Symptoms with Over-the-Counter Proton Pump Inhibitors: Issues and Proposed Guidelines
Digestion, 10/16/09 Efficacy, safety, and pharmacokinetics of intramuscular hepatitis B immune globulin, Igantibe, for the prophylaxis of viral B hepatitis after liver transplantation
Digestive and Liver Diseases, 10/16/09 Drug-Induced Steatohepatitis Leading to Cirrhosis: Long-Term Toxicity of Amiodarone Use
Seminars in Liver Disease, 10/16/09 Immunoallergic Drug-Induced Liver Injury in Humans
Seminars in Liver Disease, 10/16/09 The effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials
Colorectal Disease, 10/15/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
